Description
Key Benefits
-
Targets visible hyperpigmentation and uneven tone
-
Contains tranexamic acid, acetyl glucosamine and vitamin C
-
Provides antioxidant and skin-conditioning support
-
Suitable for professional topical/transdermal protocols
Clinical Benefits
-
Pigment Modulation: Topical tranexamic acid has evidence supporting improvement in melasma and hyperpigmentation through effects on plasmin-related signalling pathways.
-
Complementary Brightening Support: Acetyl glucosamine and ascorbic acid are used in topical formulations to support more even tone and antioxidant defence.
Product Profile
The formulation combines several actives relevant to pigmentation rather than depending on a single mechanism. Product-specific outcomes should remain framed as support for visible tone and pigmentation improvement unless substantiated by clinical studies on the exact product.
The vial format should not be interpreted as evidence of injectable classification; use should follow MCCM’s current professional topical instructions.








Reviews
There are no reviews yet.